After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Vertex Pharmaceuticals, Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $402.14 and fluctuated between $400.14 as its day high and $393.76 as its day low. The current market capitalization of Vertex Pharmaceuticals, Inc. is $103.88B. A total of 1.26 million shares were traded on the day, compared to an average of 1.16M shares.
In the most recent transaction, Ambrose Kristen sold 240 shares of VRTX for 419.00 per share on Apr 02 ’24. After the transaction, the SVP & Chief Accounting Officer now owns 7,500 company shares. In a previous transaction on Feb 26 ’24, Arbuckle Stuart A sold 5,034 shares at 425.70 per share. VRTX shares that EVP, COO owns now total 49,691.
Among the insiders who sold shares, ALTSHULER DAVID disposed of 4,239 shares on Feb 26 ’24 at a per-share price of $425.70. This resulted in the EVP, Global Research and CSO holding 25,813 shares of VRTX after the transaction. In another insider transaction, Sachdev Amit sold 3,004 shares at $425.70 per share on Feb 26 ’24. Company shares held by the EVP Chief Patient & Ext Af Off now total 55,325.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, VRTX has a high of $448.40 and a low of $320.01.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. VRTX’s latest balance sheet shows that the firm has $7.52B in Cash & Short Term Investments as of fiscal 2021. There were $967.40M in debt and $2.14B in liabilities at the time. Its Book Value Per Share was $68.22, while its Total Shareholder’s Equity was $10.10B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VRTX is Buy with a score of 4.13.
